Skip to main content

Advertisement

Log in

The BDNF val66met polymorphism is not associated with late onset Alzheimer's disease in three case–control samples

  • Scientific Correspondence
  • Published:
Molecular Psychiatry Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Egan MF et al. Cell 2003; 112: 257–269.

  2. Ventriglia M et al. Mol Psychiatry 2002; 7: 136–137.

  3. Kunugi H et al. Mol Psychiatry 2001; 6: 83–86.

  4. Riemenschneider M et al. Mol Psychiatry 2002; 7: 782–785.

  5. Combarros O et al. Dement Geriatr Cogn Disord 2004; 18: 55–58.

  6. Tsai SJ et al. Neuropsychobiology 2004; 49: 10–12.

  7. Nacmias B et al. Neurosci Lett 2004; 367: 379–383.

  8. Bagnoli S et al. Ann Neurol 2004; 55: 447–448.

  9. Nishimura AL et al. J Mol Neurosci 2004; 22: 257–260.

  10. Li Y et al. Proc Natl Acad Sci USA 2004; 101: 15688–15693.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Grupe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Rowland, C., Tacey, K. et al. The BDNF val66met polymorphism is not associated with late onset Alzheimer's disease in three case–control samples. Mol Psychiatry 10, 809–810 (2005). https://doi.org/10.1038/sj.mp.4001702

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001702

  • Springer Nature Limited

This article is cited by

Navigation